V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20127274 | 20087500 | 1.73 | 72.3 | 03 | 2017-03-08 | 2017-03-08 | EEF or EOF | 02 | N | STREPTOZOCIN | 101510282 |
| 20127300 | 20087501 | 1.52 | null | null | 2020-05-19 | 2020-05-19 | REGORAFENIB | null | Y | GEMCITABINE + OXALIPLATIN | 100887124 |
| 20127322 | 20087502 | 1.69 | 81.8 | Adjuvant (A) | 2019-10-09 | 2019-10-09 | CHOP R - 21 days | 02 | N | CAP + RT | 100078050 |
| 20127354 | 20087503 | 1.82 | 81.45 | null | 2017-11-05 | 2017-12-03 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 100668601 |
| 20127369 | 20087504 | 1.9 | 84.5 | null | 2017-07-10 | 2017-07-25 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100913871 |
| 20127387 | 20087505 | 1.59 | 86.6 | Palliative (P) | 2020-04-29 | 2020-05-26 | OXALIPLATIN | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100568877 |
| 20127589 | 20087507 | 1.47 | 70.2 | 03 | 2018-09-18 | 2018-09-18 | ESPAC TRIAL | 02 | N | HYDROXYCARBAMIDE | 100232004 |
| 20127633 | 20087508 | 1.78 | 92.3 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-09 | ESPAC-4 TRIAL | 02 | N | PLATO TRIAL | 100094974 |
| 20127665 | 20087511 | 1.73 | 94 | Palliative (P) | 2017-07-06 | 2017-07-08 | FEC 100 | 02 | N | CHLVPP/EVA | 100810912 |
| 20127992 | 20087512 | 1.77 | 47.8 | Palliative (P) | 2016-12-25 | 2017-01-08 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100081777 |
| 20128098 | 20087516 | 1.63 | 72.2 | Palliative (P) | 2016-02-20 | 2016-03-02 | ECarboX | 02 | N | ESPAC TRIAL | 100152128 |
| 20128125 | 20087517 | 1.65 | 84.5 | 03 | null | 2019-02-11 | PHITT B or C Cisplatin | null | N | HYDROXYCARBAMIDE | 101596643 |
| 20128153 | 20087518 | 1.65 | 68.6 | Palliative (P) | 2019-05-28 | 2019-05-28 | CISPLATIN + IFOSFAMIDE + MITOMYCIN | 01 | N | IRINOTECAN + MDG + PANITUMUMAB | 100371608 |
| 20128157 | 20087519 | 1.61 | 52.2 | Palliative (P) | 2018-06-15 | 2018-06-15 | Carboplatin+Fluorouracil 4 or 5 day | null | null | ARISTOTLE TRIAL | 100640510 |
| 20128237 | 20087520 | 1.56 | 112.4 | 03 | null | 2016-09-30 | FCarboSt | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100001782 |
| 20128390 | 20087523 | 1.67 | 116.5 | 03 | 2018-08-06 | 2018-08-11 | INTERAACT trial | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101565674 |
| 20128415 | 20087524 | 1.61 | 58 | Palliative (P) | 2021-02-17 | 2021-03-07 | Capecitabine+Cisplatin+Streptozocin | 02 | N | BENDAMUSTINE + RITUXIMAB | 101708384 |
| 20128425 | 20087525 | null | null | Palliative (P) | 2020-04-23 | 2020-04-23 | CAP + RT | 02 | N | PLATO TRIAL | 101186030 |
| 20128510 | 20087526 | 1.61 | 55.3 | null | 2017-08-30 | 2017-08-30 | MYELOMA XIV TRIAL | N | Y | IRINOTECAN | 100391618 |
| 20128533 | 20087527 | 1.78 | 80.6 | Palliative (P) | 2018-12-02 | 2018-12-02 | NEO-AEGIS TRIAL | 02 | N | BEVACIZUMAB + OXALIPLATIN + MdG | 100802017 |
| 20128547 | 20087528 | 1.59 | 77.9 | null | 2017-12-25 | 2017-12-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | ACTICCA-1 TRIAL | 101422385 |
| 20128598 | 20087529 | 1.8 | 83.8 | Adjuvant (A) | 2019-12-13 | 2019-12-13 | IPILIMUMAB + NIVOLUMAB | 02 | N | GEMCARBO | 100656961 |
| 20128674 | 20087530 | 1.57 | 87.6 | null | 2019-10-07 | 2019-10-07 | ECarboX | 02 | Y | CAP + RT | 100361617 |
| 20128706 | 20087531 | 1.57 | 57.3 | Adjuvant (A) | 2017-09-22 | 2017-10-03 | Cisplatin + Fluorouracil + Streptozocin | 02 | N | CARBOPLATIN + PEMETREXED | 101099294 |
| 20128711 | 20087532 | 1.71 | 79.4 | 03 | 2016-06-03 | 2016-06-12 | NAB PACLITAXEL | 02 | null | FOXTROT TRIAL | 101513469 |
| 20128758 | 20087533 | 1.48 | 59.5 | 03 | 2019-01-09 | 2019-01-15 | Palbociclib | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100056430 |
| 20128887 | 20087535 | 1.8 | 91.4 | null | 2018-05-10 | 2018-05-15 | BEP 3 day | 02 | N | IRINOTECAN | 101432174 |
| 20128905 | 20087536 | null | null | Palliative (P) | 2018-07-04 | 2018-07-08 | Cape +Cetuximab +Oxalip (3 wk) Load | 01 | N | NOT MATCHED | 100812538 |
| 20128942 | 20087537 | 1.88 | 93.3 | Palliative (P) | 2017-07-26 | 2017-08-02 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100229937 |
| 20129019 | 20087538 | 0 | 0 | Palliative (P) | 2016-06-01 | 2016-07-01 | Capecitabine + Carboplatin + RT | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101536188 |
| 20129056 | 20087539 | 1.47 | 62.1 | null | 2018-12-15 | 2018-12-15 | BENDAMUSTINE + RITUXIMAB | 2 | N | IRINOTECAN | 100477129 |
| 20129164 | 20087541 | 1.54 | 70.8 | 03 | 2019-10-16 | 2019-11-06 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | ECARBOX | 101311392 |
| 20129205 | 20087542 | 1.56 | 44 | null | 2016-11-23 | 2016-12-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | PACLITAXEL | 100994138 |
| 20129223 | 20087543 | 1.57 | 85.8 | Adjuvant (A) | 2016-11-07 | 2016-11-12 | FCiSt | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100465742 |
| 20129224 | 20087544 | 1.6 | 56 | Palliative (P) | 2018-01-23 | 2018-02-05 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100904570 |
| 20129263 | 20087545 | 1.82 | 143.6 | null | 2019-03-28 | 2019-04-04 | EVEROLIMUS | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100328540 |
| 20129291 | 20087546 | 1.62 | 51.4 | 03 | 2017-12-31 | 2018-01-20 | BORTEZOMIB + THALIDOMIDE | N | N | MELPHALAN + THALIDOMIDE | 101426232 |
| 20129371 | 20087548 | 1.77 | 64 | 03 | null | 2019-06-26 | Capecitabine + Streptozocin | N | N | EOF | 100775859 |
| 20129410 | 20087549 | 1.64 | 107 | Palliative (P) | 2020-02-19 | 2020-02-25 | SCOPE 2 TRIAL | 02 | Y | FOXTROT TRIAL | 101058908 |
| 20129429 | 20087550 | null | null | null | 2016-10-05 | 2016-10-17 | Capecitabine + Streptozocin | N | N | DOCETAXEL | 101658040 |
| 20129467 | 20087551 | 1.53 | 87 | 03 | 2019-01-18 | 2019-01-18 | IBRUTINIB | N | N | DOCETAXEL | 100197399 |
| 20129620 | 20087552 | null | 66 | Palliative (P) | 2018-10-18 | 2018-10-26 | FCarboSt | 02 | N | EVEROLIMUS | 101556988 |
| 20129622 | 20087553 | 1.57 | 59 | null | 2016-04-29 | 2016-05-14 | DABRAFENIB + TRAMETINIB | 02 | N | ARISTOTLE TRIAL | 100165495 |
| 20129641 | 20087554 | 1.6 | 16 | 03 | 2017-01-08 | 2017-01-08 | Temozolomide + RT | 01 | N | PACLITAXEL | 100046322 |
| 20129652 | 20087555 | 1.5 | 59.9 | Adjuvant (A) | 2020-03-03 | 2020-03-30 | ESHAP | 02 | N | GEMCARBO | 101248546 |
| 20129694 | 20087556 | 1.74 | 84 | Adjuvant (A) | 2016-12-20 | 2017-01-03 | Paclitaxel 7 day | N | N | NEO-AEGIS TRIAL | 100955070 |
| 20129699 | 20087557 | 1.71 | 90.4 | 03 | 2018-10-31 | 2018-11-10 | FLAG + Idarubicin | Y | N | ECARBOX | 100444251 |
| 20129917 | 20087558 | 1.69 | 72.8 | Palliative (P) | 2018-09-15 | 2018-09-22 | SCOPE 2 TRIAL | 02 | N | AZACITIDINE | 101225247 |
| 20130093 | 20087560 | 1.6 | 104 | null | 2019-02-15 | 2019-03-03 | Azacitidine | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101527510 |
| 20130142 | 20087561 | 1.83 | 55.2 | 03 | 2017-07-11 | 2017-07-11 | Carboplatin + Pemetrexed | 01 | null | CISPLATIN + RT | 101542528 |